ANIMAL CANCER FOUNDATION

EIN: 943342838 501(c)(3) Medical Research

PORT WASHINGTON, NY

Total Revenue
$318,293
Total Expenses
$825,963
Total Assets
$359,638
Net Assets
$344,193
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1999
Legal Domicile
CA
Principal Officer
BARBARA COHEN
Phone
5168584960
Tax Period
2024-07-01 to 2025-06-30

ANIMAL CANCER FOUNDATION, founded in 1999, is a small nonprofit in the Medical Research sector that reported $318K in total revenue in fiscal year 2024. Expenses of $826K exceeded revenue, resulting in a 159% operating deficit.

Mission

ANIMAL CANCER FOUNDATION IS DEDICATED TO FINDING NEW TREATMENTS AND EVENTUAL CURES FOR CANCER BY FUNDING RESEARCH IN AND INCREASING PUBLIC AWARENESS OF COMPARATIVE ONCOLOGY, THE STUDY OF NATURALLY OCCURRING, SIMILAR CANCERS IN PEOPLE AND IN COMPANION ANIMALS.

Program Service Accomplishments

Program 1
Expenses: $632,172 Revenue: $0

ANIMAL CANCER FOUNDATION HAS EMBARKED ON THE CANINE CANCER GENOME PROJECT ("CCGP") SPONSORED BY BLUE BUFFALO FOUNDATION TO ENABLE A MULTI-INSTITUTIONAL SCIENTIFIC INVESTIGATIONAL COLLABORATION TO MAP...

Read more

ANIMAL CANCER FOUNDATION HAS EMBARKED ON THE CANINE CANCER GENOME PROJECT ("CCGP") SPONSORED BY BLUE BUFFALO FOUNDATION TO ENABLE A MULTI-INSTITUTIONAL SCIENTIFIC INVESTIGATIONAL COLLABORATION TO MAP CANINE CANCER GENOMES FROM SAMPLES DONATED TO ACF BY THE CANINE CANCER ONCOLOGY GENOMICS CONSORTIUM (CCOGC) AND TO PLACE THOSE DATASETS IN THE PUBLIC DOMAIN FOR USE BY ALL CANCER RESEARCH. THIS MULTI-YEAR PROJECT WILL ENABLE CANCER SCIENTISTS TO BUILD MORE ROBUST COMPARATIVE DATASETS AND TO FURTHER CANCER RESEARCH IN PETS AND PEOPLE. AFTER A COMPETITIVE SELECTION PROCESS, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE WAS SELECTED AS THE PRINCIPAL INVESTIGATORS FOR THIS PROJECT.ACF PAID $410,000 IN SEPTEMBER 2024 AND $100,000 IN JUNE 2025 FOR CCGP. AN ADDITIONAL $200,000 IS COMMITTED TO CCGP.ACF COMPARATIVE ONCOLOGY GRANTS AWARDS ARE RESEARCH GRANTS OF $50,000 FOR ONE TO TWO YEAR COMPARATIVE ONCOLOGY RESEARCH THAT IS IDENTIFIED BY A SCIENTIFIC ADVISORY COUNCIL AS BEST-IN-FIELD EARLY DEVELOPMENT THAT WILL HAVE RESULTS POISED TO ATTRACT FURTHER GOVERNMENT AND LARGE INSTITUTIONAL FUNDING AND THAT ENCOURAGE OPEN SHARE DISCOVERY TO SPEED NEW SCIENTIFIC INFORMATION AND TREATMENT TO THE CLINICAL SETTING. THESE RFPS ARE OPENED AT THE DISCRETION OF THE ACF BOARD OF DIRECTORS.ACF SUPPORTS WORKSHOPS, SYMPOSIA AND CONFERENCES FURTHERING COMPARATIVE ONCOLOGY THAT INCLUDE THE VETERINARY CANCER SOCIETY ("VCS") ANNUAL CONFERENCE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $261,211
Program Service Revenue $0
Investment Income $56,827
Other Revenue $255
TOTAL REVENUE $318,293

Expense Breakdown

Grants Paid $510,000
Salaries & Benefits $148,727
Fundraising Expenses $115,646
Program Expenses $632,172
Other Expenses $167,236
TOTAL EXPENSES $825,963

Year-over-Year Comparison

2024 2023 Change
Revenue $318,293 $301,771 +0.1%
Expenses $825,963 $335,570 +1.5%
Net Income $-507,670 $-33,799 +14.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
6
Independent Members
6
Employees
2
Volunteers
15

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$74,000
Total Directors
6
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LONI EDWARDS DIRECTOR 3.00
Director
$0 $0 $0
GERALD POST PRESIDENT 3.00
Officer Director
$0 $0 $0
RENEE ALSARRAF SECRETARY 3.00
Officer Director
$0 $0 $0
VICTORIA CARMELLA DIRECTOR 3.00
Director
$0 $0 $0
KAREN LABARRE DIRECTOR 3.00
Director
$0 $0 $0
HAROLD ESPINOZA TREASURER 3.00
Officer Director
$0 $0 $0
BARBARA COHEN EXECUTIVE DIRECTOR 40.00
Officer
$74,000 $0 $74,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $318,293 $825,963 $359,638 $-507,670
2024 $301,771 $335,570 $897,543 $-33,799
2023 $519,863 $402,979 $930,046 $116,884
2022 $274,210 $302,326 $777,780 $-28,116
2021 $316,207 $807,314 $876,698 $-491,107
2020 $301,410 $354,302 $1,342,259 $-52,892
2019 $851,208 $373,079 $1,418,343 $478,129
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare ANIMAL CANCER FOUNDATION with other nonprofits in New York and across the country.